Recognition and optimum treatment of brucellosis

J Solera, E Martinez-Alfaro, A Espinosa - Drugs, 1997 - Springer
Brucellosis (infection with Bruceila spp.) is a common zoonosis in many parts of the world.
Human brucellosis is a multisystem disease that may present with a broad spectrum of …

Towards a Brucella vaccine for humans

SD Perkins, SJ Smither, HS Atkins - FEMS microbiology reviews, 2010 - academic.oup.com
There is currently no licensed vaccine for brucellosis in humans. Available animal vaccines
may cause disease and are considered unsuitable for use in humans. However, the …

Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations

J Ariza, M Bosilkovski, A Cascio, JD Colmenero… - PLOS …, 2007 - journals.plos.org
Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina
Recommendations | PLOS Medicine Skip to main content Advertisement PLOS Medicine …

Characteristics of and risk factors for relapse of brucellosis in humans

J Ariza, J Corredoira, R Pallares… - Clinical infectious …, 1995 - academic.oup.com
For 16 years we prospectively observed 530 adult patients with brucellosis to analyze the
characteristics of and risk factors for relapse. Clinical and laboratory findings from 86 …

Antibiotics for treating human brucellosis

R Yousefi‐Nooraie, S Mortaz‐Hejri… - Cochrane Database …, 2012 - cochranelibrary.com
Background Brucellosis is the most common zoonotic infection in the world. Several
antibiotics, separately or in combination, have been tried for treatment of human brucellosis …

Update on brucellosis: therapeutic challenges

J Solera - International journal of antimicrobial agents, 2010 - Elsevier
Brucellosis is an extremely important disease around the world, especially in developing
countries. Its clinical manifestations and severity vary with the patient population studied and …

Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla …

J Solera, M Rodriguez-Zapata, P Geijo… - Antimicrobial agents …, 1995 - Am Soc Microbiol
Brucellosis is a common zoonosis in many parts of the world; the best regimen for the
treatment of brucellosis has not been clearly determined. We have carried out a multicenter …

Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis

J Solís García del Pozo, J Solera - PloS one, 2012 - journals.plos.org
Background Brucellosis is a persistent health problem in many developing countries
throughout the world, and the search for simple and effective treatment continues to be of …

Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans

MRH Roushan, M Mohraz, M Hajiahmadi… - Clinical infectious …, 2006 - academic.oup.com
Background. In the treatment of human brucellosis, antibiotic regimens containing an
aminoglycoside are reportedly associated with fewer relapses. Methods. This prospective …

Multivariate model for predicting relapse in human brucellosis

J Solera, E Martinez-Alfaro, A Espinosa… - Journal of Infection, 1998 - Elsevier
Demographic, clinical, and laboratory data from 200 consecutive patients with acute
brucellosis were analysed with univariate and multivariate methods to identify correlates of …